Search

Carol M. Koslow

Examiner (ID: 12920, Phone: (571)272-1371 , Office: P/1734 )

Most Active Art Unit
1734
Art Unit(s)
1734, 1754, 1793, 1755, 1108
Total Applications
5011
Issued Applications
4022
Pending Applications
258
Abandoned Applications
784

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10975360 [patent_doc_number] => 20140378395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'Peptides for the Treatment of Hearing' [patent_app_type] => utility [patent_app_number] => 14/047802 [patent_app_country] => US [patent_app_date] => 2013-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 50225 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14047802 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/047802
Peptides for the Treatment of Hearing Oct 6, 2013 Abandoned
Array ( [id] => 10769043 [patent_doc_number] => 20160115199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'Cell Penetrating Peptides for Intracellular Delivery of Molecules' [patent_app_type] => utility [patent_app_number] => 14/433578 [patent_app_country] => US [patent_app_date] => 2013-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6251 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433578 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/433578
Cell penetrating peptides for intracellular delivery of molecules Oct 3, 2013 Issued
Array ( [id] => 10389773 [patent_doc_number] => 20150274780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'CONFORMATIONALLY-CONSTRAINED KINKED ENDOSOMAL-DISRUPTING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/438194 [patent_app_country] => US [patent_app_date] => 2013-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13580 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438194 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/438194
Conformationally-constrained kinked endosomal-disrupting peptides Oct 2, 2013 Issued
Array ( [id] => 9211590 [patent_doc_number] => 20140010767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'METHODS AND MATERIALS FOR PROVIDING TEETH WITH A WHITE APPEARANCE' [patent_app_type] => utility [patent_app_number] => 14/029115 [patent_app_country] => US [patent_app_date] => 2013-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9076 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14029115 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/029115
Methods and materials for providing teeth with a white appearance Sep 16, 2013 Issued
Array ( [id] => 9641943 [patent_doc_number] => 20140220054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'WT1 HLA CLASS II-BINDING PEPTIDES AND COMPOSITIONS AND METHODS COMPRISING SAME' [patent_app_type] => utility [patent_app_number] => 14/028329 [patent_app_country] => US [patent_app_date] => 2013-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24737 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028329 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/028329
WT1 HLA class II—binding peptides and compositions and methods comprising same Sep 15, 2013 Issued
Array ( [id] => 10325737 [patent_doc_number] => 20150210741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'JAGARICIN DERIVATIVES AND THEIR USE AS FUNGICIDE OR ANTITUMOR AGENT' [patent_app_type] => utility [patent_app_number] => 14/425010 [patent_app_country] => US [patent_app_date] => 2013-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9140 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14425010 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/425010
JAGARICIN DERIVATIVES AND THEIR USE AS FUNGICIDE OR ANTITUMOR AGENT Aug 21, 2013 Abandoned
Array ( [id] => 10347505 [patent_doc_number] => 20150232511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'METHOD FOR PRODUCING A COMPOSITION FOR TREATING A TOOTH LESION' [patent_app_type] => utility [patent_app_number] => 14/421666 [patent_app_country] => US [patent_app_date] => 2013-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9750 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421666 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/421666
Method for producing a composition for treating a tooth lesion Aug 13, 2013 Issued
Array ( [id] => 10339163 [patent_doc_number] => 20150224168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'COMBINATIONS WITH A BACKBONE-CYCLIZED PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/419992 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9176 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419992 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/419992
Combinations with a backbone-cyclized peptide Aug 6, 2013 Issued
Array ( [id] => 11907080 [patent_doc_number] => 09775877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'Combinations with a backbone-cyclized peptide' [patent_app_type] => utility [patent_app_number] => 14/419986 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4909 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419986 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/419986
Combinations with a backbone-cyclized peptide Aug 6, 2013 Issued
Array ( [id] => 9162042 [patent_doc_number] => 20130310319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'FAST DISSOLVING PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/952084 [patent_app_country] => US [patent_app_date] => 2013-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11370 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952084 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/952084
Fast dissolving pharmaceutical composition Jul 25, 2013 Issued
Array ( [id] => 10341736 [patent_doc_number] => 20150226740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'METHOD FOR IDENTIFYING NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS' [patent_app_type] => utility [patent_app_number] => 14/421310 [patent_app_country] => US [patent_app_date] => 2013-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 30173 [patent_no_of_claims] => 180 [patent_no_of_ind_claims] => 105 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421310 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/421310
Method for identifying novel minor histocompatibility antigens Jul 24, 2013 Issued
Array ( [id] => 11575942 [patent_doc_number] => 09631190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Cell attachment coatings and methods using phosphorous-containing photoreagent' [patent_app_type] => utility [patent_app_number] => 13/930512 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11394 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930512 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/930512
Cell attachment coatings and methods using phosphorous-containing photoreagent Jun 27, 2013 Issued
Array ( [id] => 10317247 [patent_doc_number] => 20150202250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'ANTICANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/408780 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 29131 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408780 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/408780
ANTICANCER TREATMENT Jun 24, 2013 Abandoned
Array ( [id] => 10202605 [patent_doc_number] => 20150087593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'COAGULATION FACTOR VIII WITH REDUCED IMMUNOGENICITY' [patent_app_type] => utility [patent_app_number] => 14/402922 [patent_app_country] => US [patent_app_date] => 2013-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8828 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402922 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/402922
Coagulation factor VIII with reduced immunogenicity May 20, 2013 Issued
Array ( [id] => 9691246 [patent_doc_number] => 08821836 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'SPARC binding peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/896973 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15643 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896973 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/896973
SPARC binding peptides and uses thereof May 16, 2013 Issued
Array ( [id] => 11574698 [patent_doc_number] => 09629939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Collagenous foam materials' [patent_app_type] => utility [patent_app_number] => 14/403396 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5283 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403396 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/403396
Collagenous foam materials May 15, 2013 Issued
Array ( [id] => 10256331 [patent_doc_number] => 20150141329 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-05-21 [patent_title] => 'NEURTURIN MOLECULES' [patent_app_type] => utility [patent_app_number] => 13/846281 [patent_app_country] => US [patent_app_date] => 2013-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29974 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846281 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/846281
Neurturin molecules Mar 17, 2013 Issued
Array ( [id] => 10256331 [patent_doc_number] => 20150141329 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-05-21 [patent_title] => 'NEURTURIN MOLECULES' [patent_app_type] => utility [patent_app_number] => 13/846281 [patent_app_country] => US [patent_app_date] => 2013-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29974 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846281 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/846281
Neurturin molecules Mar 17, 2013 Issued
Array ( [id] => 9844247 [patent_doc_number] => 08946163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Cross-linked collagen comprising metallic anticancer agents' [patent_app_type] => utility [patent_app_number] => 13/815834 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15454 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13815834 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/815834
Cross-linked collagen comprising metallic anticancer agents Mar 14, 2013 Issued
Array ( [id] => 10202601 [patent_doc_number] => 20150087590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'DIASPIRIN CROSSLINKED PEGYLATED HEMOGLOBIN' [patent_app_type] => utility [patent_app_number] => 14/388956 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10633 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388956 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/388956
Diaspirin crosslinked pegylated hemoglobin Mar 14, 2013 Issued
Menu